Somewhere tonight a person is taking a psychedelic with no one awake beside them. A five-part safety standard written for the FDA, drug developers, state regulators, clinics and guides, for every room a drug company's rules will never reach.
Read MoreOn 14 September 02026, the FDA held its first public hearing on psychedelic drugs as a class and ruled religious, ceremonial, and personal use out of scope. Eighty speakers, two minutes each, not one question. A letter on the gap the Notice left open.
Read MoreA brain never touches the world. What arrives is light at an angle. Inside a mushroom journey nothing new comes in. The glass you already carry gets turned. The four turns, the fear at the door, and the one dial that stays yours.
Read MoreWhat if the love you keep trying to find was never missing, only hidden behind the fear your body learned to obey? A reflection on MDMA, trauma, trust, and the strange mercy of finally feeling safe enough to receive what was always there.
Read MoreKetamine began on the battlefield as the buddy drug, given by one human who then stayed. We built an industry that forgot the second half. What integration actually is, why a clinic that listens matters, and a new partnership with Mind Body Centers.
Read MoreRed flags to watch for, questions to ask, and what real safety looks like in practice. Psychedelic education on evaluating who you trust to hold space. Not everyone offering to guide you has earned that privilege. Choose wisely.
Read MoreWhen profound experiences fade, we often blame ourselves. But memory is not the problem. Continuity is. Technology, used slowly and ethically, can help us remember what we already know.
Read MoreAn exploration of ketamine as a legal, medically supervised doorway into psychedelic healing. It explains how ketamine supports neuroplasticity, relieves depression and trauma, and complements other emerging therapies. Emphasis is on preparation, integration, safety, and sacred, heart-centered practice.
Read More
